Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1936-1950
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1936
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1936
Figure 3 Dopamine and cyclic adenosine monophosphate regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer proliferation in vivo.
A: Dopamine and cyclic adenosine monophosphate regulated phosphoprotein with an apparent Mr of 32000 (DARPP-32)-overexpressing HCT116 cells were subcutaneously implanted into the shoulders of naked mice (n = 5) to assess proliferative potential; B: After injection, carcinoma volumes were measured in the negative control (NC) group and DARPP-32 group; C: DARPP-32 and Ki67 immune staining were performed on tumor tissues from the NC and DARPP-32 groups by immunohistochemistry (blue scale bars, 100 μm; black scale bars, 50 μm). aP < 0.05; cP < 0.001.
- Citation: He K, Xie CZ, Li Y, Chen ZZ, Xu SH, Huang SQ, Yang JG, Wei ZQ, Peng XD. Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth. World J Gastrointest Oncol 2023; 15(11): 1936-1950
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1936.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1936